Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
Four elected members join the Board of Directors at the 21st Annual Meeting.
After a monthlong election, members of the American Society of Gene & Cell Therapy have elected four new members to the Society's Board of Directors, including a new incoming vice president.
Each elected member will serve a three-year term, including the incoming vice president who will enter the leadership succession line. Stephen Russell, MD, PhD will serve a yearlong term as vice president before serving as ASGCT's president-elect and, finally, president through the 2021 annual meeting.
All four of the following newly-elected members will begin their terms on the Board of Directors during the 21st Annual Meeting next month at the Hilton Chicago:
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico